Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 8:27 PM View:  | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Mar-24 | Sale (Planned) Duplicate | 25,000 | $170.95 | $4,273,680.00 | (< 1%) 3.33M to 3.3M | |
| 11-Mar-24 8:24 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Mar-24 | Private Sale (Planned) | 25,000 | $170.95 | $4,273,680.00 | (< 1%) 3.35M to 3.33M | |
| 11-Mar-24 8:27 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Mar-24 | Private Sale (Planned) | 25,000 | $170.96 | $4,274,040.00 | (< 1%) 3.35M to 3.33M | |
| 11-Mar-24 8:24 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Mar-24 | Sale (Planned) Duplicate | 25,000 | $170.96 | $4,274,040.00 | (< 1%) 3.33M to 3.3M | |
| 01-Mar-24 8:09 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise | 5,785 | $163.08 | $943,418.00 | (< 1%) 3.36M to 3.36M | |
| 01-Mar-24 8:09 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise Duplicate | 7,500 | -- | -- | < 1% 3.35M to 3.36M | |
| 01-Mar-24 8:20 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise | 2,314 | $163.08 | $377,367.00 | (10%) 22.94K to 20.62K | |
| 01-Mar-24 8:20 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 5,000 | $63.55 | $317,750.00 | 28% 17.94K to 22.94K | |
| 01-Mar-24 8:13 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise | 3,471 | $163.08 | $566,051.00 | (< 1%) 3.36M to 3.36M | |
| 01-Mar-24 8:16 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Planned Private Option Sale | 7,500 | $166.05 | $1,245,380.00 | (37%) 20.44K to 12.94K | |
| 01-Mar-24 8:13 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise Duplicate | 12,500 | -- | -- | < 1% 3.35M to 3.36M | |
| 01-Mar-24 8:09 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise Duplicate | 3,471 | $163.08 | $566,051.00 | (< 1%) 3.36M to 3.35M | |
| 01-Mar-24 8:16 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 7,500 | $63.55 | $476,625.00 | 58% 12.94K to 20.44K | < 1% |
| 01-Mar-24 8:20 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Planned Option Sale | 5,000 | $165.88 | $829,417.00 | (24%) 20.62K to 15.62K | |
| 01-Mar-24 8:13 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise Duplicate | 5,785 | $163.08 | $943,418.00 | (< 1%) 3.36M to 3.35M | |
| 01-Mar-24 8:09 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 12,500 | -- | -- | < 1% 3.34M to 3.35M | |
| 01-Mar-24 8:20 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 5,000 | -- | -- | 39% 12.94K to 17.94K | |
| 01-Mar-24 8:13 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 7,500 | -- | -- | < 1% 3.34M to 3.35M | |
| 28-Feb-24 9:33 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 27-Feb-24 | Option Exercise | 1,913 | $52.26 | $99,973.40 | 17% 11.02K to 12.94K | |
| 28-Feb-24 9:36 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Payment of Exercise | 3,791 | $157.00 | $595,187.00 | (< 1%) 3.35M to 3.34M | |
| 28-Feb-24 9:33 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Payment of Exercise | 1,533 | $157.00 | $240,681.00 | (7%) 20.64K to 19.11K | |
| 28-Feb-24 9:33 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Option Exercise | 8,087 | $52.26 | $422,627.00 | 64% 12.56K to 20.64K | |
| 28-Feb-24 9:33 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Planned Option Sale | 8,087 | $136.91 | $1,107,180.00 | (42%) 19.11K to 11.02K | |
| 28-Feb-24 9:39 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Payment of Exercise | 2,353 | $157.00 | $369,421.00 | (< 1%) 3.35M to 3.35M | |
| 24-Jan-24 5:44 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 22-Jan-24 | Option Exercise | 2,500 | $52.26 | $130,650.00 | 20% 12.56K to 15.06K | |
| 24-Jan-24 5:44 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 22-Jan-24 | Planned Option Sale | 2,500 | $130.00 | $325,000.00 | (17%) 15.06K to 12.56K | |
| 12-Dec-23 5:23 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Dec-23 | Private Sale (Planned) | 25,000 | $105.67 | $2,641,660.00 | (< 1%) 3.4M to 3.37M | |
| 12-Dec-23 5:17 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Dec-23 | Sale (Planned) Duplicate | 25,000 | $105.67 | $2,641,660.00 | (< 1%) 3.37M to 3.35M | |
| 12-Dec-23 5:23 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Dec-23 | Sale (Planned) Duplicate | 25,000 | $105.67 | $2,641,630.00 | (< 1%) 3.37M to 3.35M | |
| 12-Dec-23 5:17 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Dec-23 | Private Sale (Planned) | 25,000 | $105.67 | $2,641,630.00 | (< 1%) 3.4M to 3.37M | |
| 12-Sep-23 5:59 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Sep-23 | Private Sale (Planned) | 25,000 | $127.23 | $3,180,840.00 | (< 1%) 3.45M to 3.42M | |
| 12-Sep-23 6:01 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Sep-23 | Private Sale (Planned) | 25,000 | $127.23 | $3,180,840.00 | (< 1%) 3.45M to 3.42M | |
| 12-Sep-23 5:59 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Sep-23 | Sale (Planned) Duplicate | 25,000 | $127.23 | $3,180,840.00 | (< 1%) 3.42M to 3.4M | |
| 12-Sep-23 6:01 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 11-Sep-23 | Sale (Planned) Duplicate | 25,000 | $127.23 | $3,180,840.00 | (< 1%) 3.42M to 3.4M | |
| 09-Jun-23 7:00 PM View: | Orth Andrew C. Chief Commercial Officer | Krystal Biotech, Inc. (KRYS) | 09-Jun-23 | Planned Private Option Sale | 12,500 | $128.61 | $1,607,640.00 | (99%) 12.6K to 100 | |
| 09-Jun-23 7:03 PM View: | Janney Daniel Director | Krystal Biotech, Inc. (KRYS) | 09-Jun-23 | Sale | 18,935 | $128.77 | $2,438,220.00 | (15%) 126.3K to 107.36K | |
| 09-Jun-23 7:00 PM View: | Orth Andrew C. Chief Commercial Officer | Krystal Biotech, Inc. (KRYS) | 09-Jun-23 | Option Exercise | 12,500 | $63.55 | $794,375.00 | 12500% 100 to 12.6K | < 1% |
| 09-Jun-23 7:03 PM View: | Janney Daniel Director | Krystal Biotech, Inc. (KRYS) | 08-Jun-23 | Private Sale | 31,065 | $128.11 | $3,979,850.00 | (20%) 157.36K to 126.3K | |
| 02-Jun-23 6:23 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 31-May-23 | Sale Duplicate | 25,000 | $116.24 | $2,905,980.00 | (< 1%) 3.47M to 3.45M | |
| 02-Jun-23 6:21 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 31-May-23 | Private Sale | 25,000 | $116.24 | $2,905,980.00 | (< 1%) 3.5M to 3.47M | |
| 02-Jun-23 6:23 PM View: | Krishnan Suma President, R&D Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 31-May-23 | Private Sale | 25,000 | $116.16 | $2,903,910.00 | (< 1%) 3.5M to 3.47M | |
| 02-Jun-23 6:21 PM View: | Krishnan Krish S President and CEO Director 10% Owner | Krystal Biotech, Inc. (KRYS) | 31-May-23 | Sale Duplicate | 25,000 | $116.16 | $2,903,910.00 | (< 1%) 3.47M to 3.45M | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Option Exercise | 25,000 | $57.90 | $1,447,620.00 | 199% 12.56K to 37.56K | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Planned Option Sale | 22,479 | $109.04 | $2,451,100.00 | (60%) 37.56K to 15.08K | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Sale (Planned) | 2,521 | $109.04 | $274,889.00 | (17%) 15.08K to 12.56K | |
| 23-May-23 4:20 PM View: | Janney Daniel Director | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Private Sale (Planned) | 50,000 | $95.02 | $4,751,180.00 | (24%) 207.36K to 157.36K | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Planned Option Sale | 27,521 | $95.05 | $2,615,910.00 | (67%) 40.98K to 13.46K | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Option Exercise | 25,000 | $52.26 | $1,306,500.00 | 156% 15.98K to 40.98K | |
| 23-May-23 4:23 PM View: | Romano Kathryn Chief Accounting Officer | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Sale (Planned) | 907 | $95.05 | $86,211.70 | (7%) 13.46K to 12.56K | |
| 11-May-23 4:30 PM View: | Janney Daniel Director | Krystal Biotech, Inc. (KRYS) | 09-May-23 | Private Sale (Planned) | 17,100 | $90.74 | $1,551,580.00 | (8%) 224.46K to 207.36K |
